A study at Karbala University discusses Nesfatin 1 levels and its role in causing diabetes mellitus in Iraqi women

A master’s thesis at the Faculty of Medicine, University of Karbala, discussed the role of levels of nesfatin1, nucleobandin 2 genetic variants, in causing type 2 diabetes mellitus in obese Iraqi women.
The thesis submitted by the student Esraa Khalil Ibrahim came with the aim of evaluating the diagnostic accuracy of serum Nesfatin 1 in type 2 diabetes mellitus and its relationship to the level of C-peptide in obese and non-obese women with type 2 diabetes from the Iraqi population.
The study found a significant relationship between circulating levels of Nesfatin 1 and type 2 diabetes, as Nesfatin 1 is able to contribute to the treatment of obesity and diabetes due to its anorexic and anti-hyperglycemic effects. In addition, C-peptide is a well-known biomarker of insulin resistance and beta-cell function.